Recent clinical research in children with cystic fibrosis reported that Nanocurcumin
- Reduced inflammation throughout the body
- Reduced gut inflammation
- Increased anti-inflammatory cells
- Increased healthy weight gain
- Improved quality of life
- Reduced Pseudomonas colonies
While there is not a cure for cystic fibrosis currently, nanocurucmin should not replace medical treatment. But human studies in people with CF have shown encouraging results, particularly when highly bioavailable forms are used.
What is cystic fibrosis?
At a Glance: What Does Human Research Show?
There are one study of nanocurcumin supplementation in cystic fibrosis (not lab studies or studies in animals). - The study is from 2023.
Some text +
Table or graphic (to be sharable)
Nanocurcumin supplementation in migraine:
- Reduced inflammation throughout the body (CRP)
- Reduced inflammation in the gut (fecal calprotectin level)
- Increased anti-inflammatory cells interleukin-10 (IL-10)
- Increased healthy weight gain by 16%
- Improved quality of life
- Reduced Pseudomonas colonies by 52%
With this 2023 clinical research study in people with cystic fibrosis concluding:
'Nano-curcumin seems to be an effective nutritional supplement in patients with CF'
Curcumin supplementation in people with migraine
As of writing, there are NO studies examining turmeric or curcumin supplementation in people with migraine. So taking turmeric or even curcumin supplements is unlikely to help migraine.
The Problem with Standard Curcumin
One of the biggest challenges with conventional curcumin supplements is that very little is absorbed after it is swallowed.
This poor absorption means that although curcumin has impressive biological activity in laboratory studies, much less reaches the bloodstream and tissues in humans where it can have benefit.
This may help explain why clinical studies using standard curcumin have often produced disappointing results.
Nanocurcumin: A Better Form of Curcumin
Nanocurcumin is designed to overcome one of the biggest limitations of conventional curcumin by dramatically improving its absorption.
Because the curcumin particles are much smaller, more of the active compound can reach the bloodstream and the tissues where it is needed and can have benefit.
This improved bioavailability has led researchers to investigate whether nanocurcumin may produce better clinical outcomes from standard curcumin.
Nanocurcumin and other immune and inflammation issues:
MS
Migraine
A 2020 lab study reported that nanocurcumin reduced the growth of Pseudomonas aeruginosa (Pseudomonas aeruginosa is a bacterium that can cause difficult-to-treat infections, especially in people with cystic fibrosis).
A 2025 lab study reported that curcumin might reduce airway inflammation and damage in CF.
References
